全文获取类型
收费全文 | 13128篇 |
免费 | 1005篇 |
国内免费 | 367篇 |
专业分类
耳鼻咽喉 | 2224篇 |
儿科学 | 269篇 |
妇产科学 | 107篇 |
基础医学 | 1259篇 |
口腔科学 | 109篇 |
临床医学 | 1352篇 |
内科学 | 1555篇 |
皮肤病学 | 103篇 |
神经病学 | 878篇 |
特种医学 | 392篇 |
外国民族医学 | 3篇 |
外科学 | 843篇 |
综合类 | 2160篇 |
现状与发展 | 5篇 |
预防医学 | 876篇 |
眼科学 | 129篇 |
药学 | 860篇 |
9篇 | |
中国医学 | 522篇 |
肿瘤学 | 845篇 |
出版年
2024年 | 25篇 |
2023年 | 168篇 |
2022年 | 288篇 |
2021年 | 484篇 |
2020年 | 445篇 |
2019年 | 423篇 |
2018年 | 426篇 |
2017年 | 499篇 |
2016年 | 509篇 |
2015年 | 472篇 |
2014年 | 865篇 |
2013年 | 840篇 |
2012年 | 908篇 |
2011年 | 877篇 |
2010年 | 686篇 |
2009年 | 601篇 |
2008年 | 670篇 |
2007年 | 724篇 |
2006年 | 592篇 |
2005年 | 512篇 |
2004年 | 410篇 |
2003年 | 367篇 |
2002年 | 323篇 |
2001年 | 294篇 |
2000年 | 227篇 |
1999年 | 228篇 |
1998年 | 184篇 |
1997年 | 175篇 |
1996年 | 159篇 |
1995年 | 138篇 |
1994年 | 123篇 |
1993年 | 119篇 |
1992年 | 80篇 |
1991年 | 66篇 |
1990年 | 65篇 |
1989年 | 47篇 |
1988年 | 43篇 |
1987年 | 49篇 |
1986年 | 40篇 |
1985年 | 60篇 |
1984年 | 67篇 |
1983年 | 36篇 |
1982年 | 48篇 |
1981年 | 30篇 |
1980年 | 26篇 |
1979年 | 29篇 |
1978年 | 25篇 |
1977年 | 13篇 |
1976年 | 6篇 |
1975年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
《Vaccine》2020,38(3):570-577
IntroductionPediatric pneumococcal pneumonia complicated by parapneumonic pleural effusion/empyema (PPE/PE) remains a major concern despite general immunization with pneumococcal conjugate vaccines (PCVs).MethodsIn a nationwide pediatric hospital surveillance study in Germany we identified 584 children <18 years of age with bacteriologically confirmed PPE/PE from October 2010 to June 2018. Streptococcus pneumoniae was identified by culture and/or PCR of blood samples and/or pleural fluid and serotyped.ResultsS. pneumoniae was identified in 256 of 584 (43.8%) children by culture (n = 122) and/or PCR (n = 207). The following pneumococcal serotypes were detected in 114 children: serotype 3 (42.1%), 1 (25.4%), 7F (12.3%), 19A (7.9%), other PCV13 serotypes (4.4%) and non-PCV13 serotypes (7.9%). Between October 2010 and June 2014 serotype 1 (38.1%) and serotype 3 (25.4%) were most prevalent, whereas between July 2014 and June 2018 serotype 3 (62.7%) and non-PCV13 serotypes (15.7%) were dominant. Compared to children with other pneumococcal serotypes, children with serotype 3 associated PPE/PE were younger (median 3.2 years [IQR 2.1–4.3 years] vs. median 5.6 years [IQR 3.8–8.2 years]; p < 0.001) and more frequently admitted to intensive care (43 [89.6%] vs. 48 [73.8%]; p = 0.04). Seventy-six of 114 (66.7%) children with pneumococcal PPE/PE had been vaccinated with pneumococcal vaccines. Thirty-nine of 76 (51.3%) had received a vaccine covering the serotype detected. Thirty of these 39 breakthrough cases were age-appropriately vaccinated with PCV13 and considered vaccine failures, including 26 children with serotype 3, three children with serotype 19A and one child with serotype 1.ConclusionFollowing the introduction of PCV13 in general childhood vaccination we observed a strong emergence of serotype 3 associated PPE/PE in the German pediatric population, including a considerable number of younger children with serotype 3 vaccine breakthrough cases and failures. Future PCVs should not only cover newly emerging serotypes, but also include a more effective component against serotype 3. 相似文献
3.
4.
5.
《Revista brasileira de otorrinolaringologia (English ed.)》2022,88(5):803-811
ObjectivesTo review the evidence pertaining to the association between cow’s milk protein allergy and recurrent acute otitis media and otitis media with effusion.MethodsThe CENTRAL, Web of Science, EMBASE, MEDLINE, LILACS databases, and gray literature were searched.ResultsFour studies were included, identifying the prevalence rates: 0.2% of delayed speech due to chronic otitis media with effusion in 382 children with cow’s milk protein allergy, 10.7% of cow’s milk protein allergy in 242 children who underwent ENT procedures, 40% of cow’s milk protein allergy in 25 children with recurrent otitis media with effusion and higher tendency to otitis media in children with cow’s milk protein allergy of 186 children (1.5 + 0.6 vs. 0.4 + 0.1; p < 0.1).ConclusionConsidering the characteristics and methodological variations of the identified studies, it is not possible to state that there is reliable evidence of an association between cow’s milk protein allergy and otitis media. 相似文献
6.
Uday Yanamandra Prateek Deo Kamal Kant Sahu Ram Vasudevan Nampoothiri Nalini Gupta Anusree Prabhakaran Deb Prasad Dhibhar Alka Khadwal Gaurav Prakash Man Upadesh Singh Sachdeva Deepesh Lad Neelam Varma Subhash Varma Pankaj Malhotra 《Clinical Lymphoma, Myeloma & Leukemia》2019,19(3):183-189.e1
Background
Multiple myeloma (MM) is a hematologic malignancy of plasma cell origin. MM primarily affects bone marrow, but extramedullary sites can also be involved. Myelomatous pleural effusion (MPE) is an atypical and rare complication of MM. We aimed to systematically study the incidence and clinicopathologic profile of patients with MPE in a real-world setting.Patients and Methods
In this retrospective study, 415 consecutive patients with MM managed at a tertiary care center in North India during a study period of January 1, 2010 to December 31, 2015 were evaluated for MPE. The patients with MPE were analyzed for their clinical profile, diagnosis, treatment, and outcomes.Results
Of these 415 patients, 11 (2.65%) patients had MPE. The median age of the study population was 50 years with male preponderance. The majority of these patients had immunoglobin (Ig)G Kappa disease. All patients had higher than International Staging System stage I disease. MPE was a presenting feature at MM diagnosis in 45.45% (n = 5) of the patients, whereas the rest developed MPE during follow-up. MPE presented predominantly (81.8%) as a unilateral effusion. Concurrent extramedullary involvement at other site was seen in 45.45% (n = 5), with 3 (27%) patients having concurrent myelomatous ascites. Six of these were managed aggressively, whereas 5 patients opted for palliation. The outcomes were dismal (90.9% mortality), with a median survival of 2.47 months.Conclusion
MPE is a rare entity, and positive outcomes of therapy remain low with dismal prognosis. 相似文献7.
8.
9.
10.
目的 探讨米索前列醇联合依沙吖啶在中晚期妊娠引产中的应用效果。方法 选取西安交通大学附属3201医院2012年1月—2017年12月收治的138例中晚期妊娠引产患者,按引产方式分为对照组、观察组,各69例。对照组使用乳酸依沙吖啶注射液进行引产,观察组在对照组的基础上联合使用米索前列醇进行引产。比较两组引产效果、胎儿娩出时间、阴道出血量及不良反应的发生情况。结果 观察组引产有效率是100%,显著高于对照组的91.75%(P<0.05)。观察组胎儿娩出时间<35 h的人数占比显著高于对照组(P<0.05)。观察组患者阴道出血量显著低于对照组(P<0.05),两组不良反应的发生率间差异不显著。结论 米索前列醇联合依沙吖啶在中晚期妊娠引产中的效果较好,可显著提高引产有效率、缩短胎儿娩出时间,值得临床应用。 相似文献